Anlon Healthcare

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0Y8W01017
  • NSEID: AHCL
  • BSEID: 544497
INR
125.00
0.95 (0.77%)
BSENSE

Feb 06

BSE+NSE Vol: 96.04 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationUpcoming Result: Anlon Healthcare will declare its result soon on 09 Feb 2026
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

96.04 k (0.10%) Volume

Shareholding (Dec 2025)

FII

0.23%

Held by 4 FIIs

DII

4.40%

Held by 1 DIIs

Promoter

52.68%

When is the next results date for Anlon Healthcare Ltd?

04-Feb-2026

The next results date for Anlon Healthcare Ltd is 09 February 2026.

The next results date for Anlon Healthcare Ltd is scheduled for 09 February 2026.

View full answer

Why is Anlon Healthcare Ltd falling/rising?

07-Feb-2026

As of 07-Feb, Anlon Healthcare Ltd's stock price is rising to 125.00, but it has declined 15.37% over the past month and 17.41% year-to-date, indicating a concerning overall trend despite short-term gains. Additionally, investor participation has decreased significantly, with delivery volume down 25.89% compared to the 5-day average.

As of 07-Feb, Anlon Healthcare Ltd's stock price is rising, currently at 125.00, with a change of 0.95 (0.77%) upward. This increase is supported by the stock's performance today, where it outperformed its sector by 1.57%. Additionally, the stock has shown a positive return of 2.12% over the past week, which is higher than the Sensex's return of 1.59% during the same period. <BR><BR>However, it is important to note that the stock has experienced a significant decline over the past month, with a decrease of 15.37%, and a year-to-date decline of 17.41%. Despite this recent upward movement, the stock is still below its longer-term moving averages, indicating that while there may be short-term gains, the overall trend remains concerning. Furthermore, there has been a notable decrease in investor participation, with delivery volume falling by 25.89% against the 5-day average. <BR><BR>In summary, while Anlon Healthcare Ltd is currently experiencing a rise in stock price, this is juxtaposed against a backdrop of recent declines and reduced investor activity, suggesting a complex situation for the stock.

View full answer

Which are the latest news on Anlon Healthcare?

08-Feb-2026

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 651 Cr (Micro Cap)

stock-summary
P/E

32.00

stock-summary
Industry P/E

32

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.07

stock-summary
Return on Equity

9.57%

stock-summary
Price to Book

3.08

Revenue and Profits:
Net Sales:
52 Cr
(Quarterly Results - Sep 2025)
Net Profit:
9 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-9.22%
0%
-9.22%
6 Months
0%
0%
0.0%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Anlon Healthcare for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

The Company Has Purchased A Commercial Office At Ahmedabad Gujarat And Shall Be Used For Marketing Office.

05-Feb-2026 | Source : BSE

We have attached herewith announcement as per Reg. 30 of SEBI (LODR) Regulation 2015. Kindly take the same on your record. Thank you.

Board Meeting Intimation for Consideration And Approve The Financial Results For The Quarter Ended December 31 2025

03-Feb-2026 | Source : BSE

Anlon Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve 1. To consider and approve the Unaudited Standalone Financial Results along with Limited Review Report by Auditor thereon of the Company for the quarter and nine months ended on December 31 2025. 2. Any other business(s) with permission of the Chair if any. Kindly take the same on your record. Thank you.

Intimation As Per Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (The Listing Regulations) - Development Of New Product

28-Jan-2026 | Source : BSE

We have attached herewith intimation as per Regulation 30 of SEBI (LODR) Regulation 2015. Kindly take the same on your record. Thank you.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

09 Feb 2026

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
65.60%
EBIT Growth (5y)
58.45%
EBIT to Interest (avg)
8.18
Debt to EBITDA (avg)
2.57
Net Debt to Equity (avg)
0.70
Sales to Capital Employed (avg)
0.86
Tax Ratio
23.69%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
4.72%
ROCE (avg)
9.07%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
32
Industry P/E
32
Price to Book Value
3.10
EV to EBIT
22.30
EV to EBITDA
21.08
EV to Capital Employed
2.97
EV to Sales
5.64
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
13.30%
ROE (Latest)
9.57%

Technicals key factors

Indicator
Weekly
Monthly
Icon
No records
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 4 FIIs (0.23%)

Promoter with highest holding

Punitkumar R Rasadia (34.98%)

Highest Public shareholder

Shree Dwarikadhish Ventures Llp (0.075%)

Individual Investors Holdings

23.58%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 56.76% vs 37.77% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 162.54% vs 37.07% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "52.20",
          "val2": "33.30",
          "chgp": "56.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "13.73",
          "val2": "6.24",
          "chgp": "120.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.87",
          "val2": "0.82",
          "chgp": "6.10%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "9.32",
          "val2": "3.55",
          "chgp": "162.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.30%",
          "val2": "18.74%",
          "chgp": "7.56%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "85.50",
          "val2": "62.00",
          "chgp": "37.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "19.98",
          "val2": "14.45",
          "chgp": "38.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.68",
          "val2": "1.91",
          "chgp": "-12.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "12.86",
          "val2": "6.36",
          "chgp": "102.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.37%",
          "val2": "23.31%",
          "chgp": "0.06%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Jun'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "95.30",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "20.69",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "2.73",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "9.91",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.71%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "120.29",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "32.21",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "3.72",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "20.52",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.78%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Sep'25 - QoQstock-summary

Sep'25
Jun'25
Change(%)
Net Sales
52.20
33.30
56.76%
Operating Profit (PBDIT) excl Other Income
13.73
6.24
120.03%
Interest
0.87
0.82
6.10%
Exceptional Items
0.00
0.00
Standalone Net Profit
9.32
3.55
162.54%
Operating Profit Margin (Excl OI)
26.30%
18.74%
7.56%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Sep 2025 is 56.76% vs 37.77% in Jun 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Sep 2025 is 162.54% vs 37.07% in Jun 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
85.50
62.00
37.90%
Operating Profit (PBDIT) excl Other Income
19.98
14.45
38.27%
Interest
1.68
1.91
-12.04%
Exceptional Items
0.00
0.00
Standalone Net Profit
12.86
6.36
102.20%
Operating Profit Margin (Excl OI)
23.37%
23.31%
0.06%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Nine Monthly Results Snapshot (Standalone) - Jun'25stock-summary

Jun'25
Change(%)
Net Sales
95.30
NA
NA
Operating Profit (PBDIT) excl Other Income
20.69
NA
NA
Interest
2.73
NA
NA
Exceptional Items
0.00
NA
NA
Standalone Net Profit
9.91
NA
NA
Operating Profit Margin (Excl OI)
21.71%
NA%
NA
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Change(%)
Net Sales
120.29
NA
NA
Operating Profit (PBDIT) excl Other Income
32.21
NA
NA
Interest
3.72
NA
NA
Exceptional Items
0.00
NA
NA
Standalone Net Profit
20.52
NA
NA
Operating Profit Margin (Excl OI)
26.78%
NA%
NA
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

stock-summaryCompany CV
About Anlon Healthcare Ltd stock-summary
stock-summary
Anlon Healthcare Ltd
Micro Cap
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available